Harry Gillis
Stock Analyst at Berenberg Bank
(3.67)
# 2,009
Out of 4,339 analysts
66
Total ratings
52.3%
Success rate
10.8%
Average return
Main Sectors:
Stocks Rated by Harry Gillis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTX BioNTech SE | Maintained: Buy | $155 → $140 | $92.14 | +51.94% | 12 | May 11, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Maintained: Buy | $500 → $515 | $447.20 | +15.16% | 17 | Apr 28, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Upgraded: Buy | $215 → $250 | $234.50 | +6.61% | 3 | Apr 24, 2026 | |
| SWX: TECN Tecan Group AG | Maintained: Buy | $205 | $149.40 | +37.22% | 7 | Apr 21, 2026 | |
| ATAI AtaiBeckley | Maintained: Buy | $13 → $14 | $4.32 | +224.07% | 10 | Apr 20, 2026 | |
| QGEN Qiagen | Maintained: Buy | $46 → $50 | $35.17 | +42.17% | 7 | Feb 12, 2026 | |
| MRNA Moderna | Maintained: Hold | $26 → $32 | $46.88 | -31.74% | 10 | Jan 22, 2026 |
BioNTech SE
May 11, 2026
Maintained: Buy
Price Target: $155 → $140
Current: $92.14
Upside: +51.94%
Swedish Orphan Biovitrum AB (publ)
Apr 28, 2026
Maintained: Buy
Price Target: $500 → $515
Current: $447.20
Upside: +15.16%
Sartorius Aktiengesellschaft
Apr 24, 2026
Upgraded: Buy
Price Target: $215 → $250
Current: $234.50
Upside: +6.61%
Tecan Group AG
Apr 21, 2026
Maintained: Buy
Price Target: $205
Current: $149.40
Upside: +37.22%
AtaiBeckley
Apr 20, 2026
Maintained: Buy
Price Target: $13 → $14
Current: $4.32
Upside: +224.07%
Qiagen
Feb 12, 2026
Maintained: Buy
Price Target: $46 → $50
Current: $35.17
Upside: +42.17%
Moderna
Jan 22, 2026
Maintained: Hold
Price Target: $26 → $32
Current: $46.88
Upside: -31.74%